Tesamorelin + Ipamorelin 40 mg

This research blend contains 20 mg of tesamorelin and 20 mg of ipamorelin, two synthetic peptides studied for their activity within growth-hormone signalling pathways. Tesamorelin is a growth hormone-releasing hormone analogue, while ipamorelin is a selective growth hormone secretagogue and ghrelin-receptor agonist.

Product Description:

This research blend contains 20 mg of tesamorelin and 20 mg of ipamorelin, two synthetic peptides studied for their activity within growth-hormone signalling pathways. Tesamorelin is a growth hormone-releasing hormone analogue, while ipamorelin is a selective growth hormone secretagogue and ghrelin-receptor agonist.

The components have been investigated in research relating to growth-hormone release, IGF-1 signalling, body composition, adipose-tissue metabolism, muscle biology, recovery pathways, and age-associated metabolic changes. The safety and effectiveness of this combined formulation for any therapeutic application have not been established.

Additional Details:

  • Tesamorelin: 20 mg
  • Ipamorelin: 20 mg
  • Total quantity: 40 mg per vial
  • Classification: Research peptide blend
  • Research pathway: Growth hormone and IGF-1 signalling
  • Intended use: Laboratory research only

View Certificate of Analysis(COA)

Review third-party analytical testing data to verify quality and specifications prior to study.

Important notice

This Tesamorelin + Ipamorelin 40 mg blend is not a medicine or consumer product. It is not intended for human or veterinary use, ingestion, injection, compounding, diagnosis, treatment, cure, or prevention of disease. The stated 40 mg quantity represents total vial contents-not a recommended dose.

Scroll to Top
AGE & RESEARCH CONFIRMATION

Before You explore

Our collection is supplied exclusively for research and analytical use. Please confirm the following to enter.

Not for human consumption or therapeutic use.